Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study

Author:

Pronzato P.1,Mustacchi G.2,De Matteis A.3,Di Costanzo F.4,Rulli E.5,Floriani I.5,Cazzaniga M. E.6ORCID

Affiliation:

1. Oncologia Medica, IST, Genova 16010, Italy

2. Medical Oncology Department, University of Trieste, Trieste 34010, Italy

3. Medical Oncology C, National Cancer Institute, G. Pascale Foundation, Napoli 80010, Italy

4. Medical Oncology, Careggi University Hospital, Firenze 50012, Italy

5. Oncology Department, Mario Negri Institute for Pharmacological Research, Milano 20100, Italy

6. Medical Oncology, San Gerardo Hospital, Az Osp San Gerardo, Via Pergolesi 33, 20052 Monza, Italy

Abstract

Background. The present paper described the biological characteristics and clinical behavior of young women in the cohort NORA studyPatients and Methods. From 2000–2002, patients () were enrolled at 77 Italian hospitals. Women aged years () were stratified into age groups (, 36–40, 41–45, and 46–50 years). The relationship between age and patient characteristics, cancer presentation, and treatment was analyzed.Results. Younger women more frequently had tumors with ER/PgR-negative(; ), HER2 amplification (; ), and high () Ki67 labelling index (; ). Positive nodal status, large tumors, and elevated Ki67 all associated with the choice for chemotherapy followed by endocrine therapy in hormone receptor-positive patients (). At univariate analysis, ER-ve status, chemotherapy and age resulted as the only statistically significant variables (, , and versus , , resp.). At multivariate analysis, after adjustment for significant clinical and pathological factors, age remains a significant prognostic variable (, ).Conclusion. This cohort study suggests that ageper sèis an important prognostic factor. The restricted role of early diagnosis and the aggressive behavior of cancer in this population make necessary the application of targeted medical strategies crucial.

Publisher

Hindawi Limited

Subject

Cancer Research,Pharmacology (medical),Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3